Abstract:Novel monometallic and heterobimetallic complexes of Zn (II) were synthesized. The newly designed complexes were characterized by infrared (FT‐IR), nuclear magnetic resonance (NMR), electron spray ionization mass spectrometry, powder X‐ray diffraction, molar conductivity, and UV–vis. Density functional theory calculations were performed to calculate the stability and chemical reactivity of the newly designed Zn (II) complexes. In vitro antimicrobial, anti‐inflammatory, and anticancer activities of the newly synthesized complexes were evaluated. In the present work, new heterobimetallic complexes with the general formula [Zn(C16H32N8)M2(R)4Cl2], where M = Sn (IV) and Si (IV) and R = ‐CH3 and ‐C6H5, were synthesized by reacting the methanolic solution of the monometallic complex [Zn(C16H36N8)Cl2] with group 14 organometallic dichloride [(CH3)2SnCl2/(C6H5)2SnCl2/(CH3)2SiCl2/(C6H5)2SiCl2]. The structures of the synthesized complexes were determined using several spectrometric techniques, including FT‐IR, 1H NMR, 13C NMR, 119Sn NMR, 29Si NMR, ESI‐MS, PXRD, and molar conductivity measurements. Density functional theory (DFT) calculations were carried out to investigate the quantum chemical characteristics of the newly synthesized Zn (II) complexes. The antimicrobial potential of the monometallic and heterobimetallic complexes was evaluated against two Gram‐positive bacteria (Bacillus subtilis and Bacillus cereus), two Gram‐negative bacteria (Xanthomonas campestris and Pseudomonas aeruginosa), and two fungal strains (Aspergillus flavus and Fusarium oxysporum) by the agar well diffusion method, with heterobimetallic complex [Zn(C16H32N8)Sn2(C6H5)4Cl2] as the most potent complex against microbes. The complex [Zn(C16H32N8)Sn2(C6H5)4Cl2] exhibited significant potential in inhibiting inflammation, demonstrating an IC50 value of 9.75 μg/mL, which closely rivals that of the standard drug sodium diclofenac (IC50 = 4.59 μg/mL). Furthermore, all the synthesized compounds were assessed for their anticancer potential against three cancer cell lines (HCT‐116, MCF‐7, and HeLa) by the MTT assay. The results indicated that the complex [Zn(C16H32N8)Sn2(C6H5)4Cl2] exhibited the most pronounced cytotoxic effects, with values of 4.25 ± 0.15 μM, 4.90 ± 0.18 μM, and 5.20 ± 0.24 μM observed for HCT‐116, MCF‐7, and HeLa cancer cell lines, respectively.

Zinc-aspirin complex: synthesis, physicochemical and biological evaluation

Zinc-oxaprozin compounds: Synthesis, structure and biological activity

Synthesis, Characterization, and Biological Evaluation of a Novel Zn(II)-Naproxen Complex

Ibuprofen: A multi-purpose active pharmaceutical ingredient as versatile ligand for zinc(II) and copper(II). Solid state and solution studies

Synthesis of Novel [{(2-Amino-5-Nitro-N-[(E)-Thiophen-2-yl-Methylidene]Aniline-κ3N1:N4:S)(Sulphato-κ2O1:O3)}Zinc(II)] Complex with Physico-Chemical and Biological Perspective Exploration: A Combined Experimental and Computational Studies

Zinc complexes of chloroquine and hydroxychloroquine versus the mixtures of their components: Structures, solution equilibria/speciation and cellular zinc uptake

COMPARATIVE SYNTHESIS, SPECTRAL AND ANTIMICROBIAL STUDIES OF METAL (II) COMPLEXES DERIVED FROM ASPIRIN

Synthesis, Structural Elucidation, Density Functional Theory Calculations, In Vitro Antimicrobial, Anti‐Inflammatory and Anticancer Activities of Novel Zn (II)‐Group Fourteen Heterobimetallic Complexes Derived From Schiff Base Ligand

Effects of Copper-Aspirin Complex on Platelet Aggregation and Thrombosis in Rabbits and Mice

Structural investigations and antibacterial, antifungal and anticancer studies on zinc salicylaldimine complexes

Structure, Molecular Simulation, and Release of A Spirin from Intercalated Zn-Al-Layered Double Hydroxides

Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation

New Complexes with Triazole Schiff Bases Derivative Ligand Containing Aspirin: Synthesis, Structure, Conductivity and Magnetic Susceptibility

Synthesis, Spectral Characterization In Vitro Biological and Pharmacokinetics Studies of Biologically Active Copper and Zinc Metal Chelates with 4-Mercaptoaniline and Nitrite Ion

Novel Zn(II) heterobimetallic complexes: synthesis, characterization, density functional theory calculations, in vitro antimicrobial, anti-inflammatory and anticancer activities

A novel zinc complex with antibacterial and antioxidant activity

Anticancer and Anti-Inflammatory Mechanisms of NOSH-Aspirin and Its Biological Effects

Novel conjugates of aspirin with phenolic acid as anti-inflammatory agents having significantly reduced gastrointestinal toxicity.

Gastroprotective Effects of a New Zinc(ii)–curcumin Complex Against Pylorus-Ligature-induced Gastric Ulcer in Rats

Piroxicam analogue metal complexes: Synthesis, crystal structures, molecular modeling and biological studies

Zinc improves antibacterial, anti-inflammatory and cell motility activity of chitosan for wound healing applications